Status:
RECRUITING
Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Parkinson's Disease (PD)
Tremor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by different motor symptoms, including tremor, which is particularly difficult to manage. Common treatments, such as do...
Detailed Description
Parkinson's disease (PD) is the second most common neurodegenerative disorder, characterized by progressive neurodegeneration, especially in the substantia nigra. Clinically, PD is characterized by mo...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Parkinson's disease based on UK Brain Bank criteria
- Patient exhibiting moderate to severe hand tremor
- Provision written informed consent by the patient
Exclusion
- History of other neurological disorders such as vascular malformations, ischemic or haemorrhagic stroke, cerebral neoplasia, epilepsy, or major psychiatric illness
- Existence of heart pacemaker or metal implants in the body
- Pregnancy
Key Trial Info
Start Date :
April 16 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06993571
Start Date
April 16 2025
End Date
December 31 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Hamburg, Germany, 20246